Profil
Xiao Ping Dai is currently the Chief Technical Officer at IVERIC bio, Inc. Prior to this, she worked as the Senior Director-Biologics Development at Celgene Corp.
from 2014 to 2018, and as the Chief Technologist & VP-Technology Development at WuXi Advanced Therapies, Inc. from 2018 to 2019.
She holds a doctorate degree from the New Jersey Institute of Technology.
Postes actifs de Xiao Ping Dai
| Sociétés | Poste | Début |
|---|---|---|
| IVERIC BIO, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Xiao Ping Dai
| Sociétés | Poste | Fin |
|---|---|---|
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Directeur Technique/Scientifique/R&D | 01/10/2019 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Formation de Xiao Ping Dai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
New Jersey Institute of Technology
New Jersey Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
WuXi Advanced Therapies, Inc.
WuXi Advanced Therapies, Inc. BiotechnologyHealth Technology Engages in development, testing, manufacturing and commercialization of cell & gene therapies | Health Technology |
















